Several studies investigating obesity in murine models suggest interplay between alterations in gut microbiota, CB1 receptor activation and its ligands (e.g., arachidonoyl ethanolamide) promote gut permeability, which along with obesity-induced inflammation can be readily ameliorated by CB1 blockade [51–53]. Here, CNR1 is linked to obesity due to melanocortin 4 receptor deficiency.